{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T22:34:39Z","timestamp":1789079679676,"version":"build-2803163510"},"reference-count":30,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2010,8,30]],"date-time":"2010-08-30T00:00:00Z","timestamp":1283126400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J Dermatology"],"published-print":{"date-parts":[[2010,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> Antimicrobials are essential in acne therapy. In the last decades, <jats:italic>Propionibacterium acnes<\/jats:italic> has become resistant to different antibiotics.<\/jats:p><jats:p><jats:bold>Objective\u2002<\/jats:bold> To determine antimicrobial susceptibility patterns of <jats:italic>P. acnes<\/jats:italic> to frequently used drugs.<\/jats:p><jats:p><jats:bold>Materials and methods\u2002<\/jats:bold> Cutaneous lesion samples were obtained from 50 patients with acne vulgaris, which were cultured in anaerobic media to demonstrate the presence of <jats:italic>P. acnes<\/jats:italic>. After that, antimicrobial susceptibility tests to tetracycline, minocycline, doxycycline, erythromycin, azithromycin, clindamycin, trimethoprim\/sulfamethoxazole (SXT) and levofloxacin were performed.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> In the general study group, resistance to azithromycin was 82%, the most prevalent one (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.05), followed by trimethoprim\/sulfamethoxazole (68%) and erythromycin (46%). On the other hand, all strains isolated were susceptible to minocycline. Resistance bias were similar when subgroups with and without the previous antimicrobial therapy were performed, finding a low prevalence of resistance to tetracyclines and levofloxacin in both groups.<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> In our region, <jats:italic>P. acnes<\/jats:italic> is highly resistant to azithromycin, SXT, erythromycin and clindamycin; and being very susceptible to minocycline, levofloxacin and tetracycline, <jats:italic>in vitro<\/jats:italic> in both groups: with and without the previous antibiotic use. To our knowledge, high resistance prevalence to azithromycin and SXT has never been reported.<\/jats:p>","DOI":"10.1111\/j.1365-4632.2010.04506.x","type":"journal-article","created":{"date-parts":[[2010,9,11]],"date-time":"2010-09-11T00:14:59Z","timestamp":1284164099000},"page":"1003-1007","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Report: <i>In vitro<\/i> antimicrobial susceptibility of <i>Propionibacterium acnes<\/i> isolated from acne patients in northern Mexico"],"prefix":"10.1111","volume":"49","author":[{"given":"Roger","family":"Gonz\u00e1lez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliverio","family":"Welsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Ocampo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa M.","family":"Hinojosa\u2010Robles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucio","family":"Vera\u2010Cabrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary L.","family":"Delaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minerva","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,8,30]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.50.1.379-381.2006"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1080\/00015550310016463"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.anaerobe.2004.02.002"},{"key":"e_1_2_5_5_2","first-page":"197","article-title":"[Presence of IL\u201012, IL\u20102, and INF\u2010\u03b3 in inflammatory acne]","volume":"50","author":"Palma\u2010Ramos A","year":"2006","journal-title":"Dermatolog\u00eda Rev Mex"},{"key":"e_1_2_5_6_2","first-page":"101","article-title":"[Bacterial etiology and antibiotic susceptibility in patients with acne]","volume":"15","author":"Rodr\u00edguez\u2010Cavallini E","year":"2004","journal-title":"Rev Biomed"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2004.01887.x"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.34.4.1024-1026.1996"},{"key":"e_1_2_5_9_2","first-page":"1","article-title":"Methods for antimicrobial susceptibility testing of anaerobic bacteria; Approved standard\u2010seventh edition","volume":"27","author":"Hecht DW","year":"2007","journal-title":"CLSI M11-A7"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2006.03.028"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2002.04690.x"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2004.01055.x"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2003.05067.x"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2008.07.004"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1989.tb01399.x"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.1390s3004.x"},{"key":"e_1_2_5_17_2","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1365-2133.1996.d01-733.x","article-title":"The effect of acne treatment with a combination of benzoyl peroxide and erythromycin on skin carriage of erythromycin\u2010resistant propionibacteria","volume":"134","author":"Eady EA","year":"1996","journal-title":"Br J Dermatol"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1999.03132.x"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2001.03956.x"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0934-8840(99)80123-6"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0001-7310(02)76573-3"},{"key":"e_1_2_5_22_2","first-page":"14","article-title":"[Antimicrobial susceptibility of strains of Propionibacterium acnes isolated from inflammatory acne]","volume":"48","author":"G\u00fcbelin W","year":"2006","journal-title":"Rev Latinoam Microbiol"},{"key":"e_1_2_5_23_2","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1128\/AAC.41.5.1162","article-title":"Clinical resistance to erythromycin and clindamycin in cutaneous propionibacteria isolated from acne patients in associated with mutations in 23S rRNA","volume":"41","author":"Ross JI","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/49.1.165"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1348-0421.2008.00081.x"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.08286.x"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.1988.tb03667.x"},{"key":"e_1_2_5_28_2","first-page":"25","article-title":"Antimicrobial susceptibility of Propionibacterium acnes isolated from acne vulgaris","volume":"9","author":"Kurokawa I","year":"1999","journal-title":"Eur J Dermatol"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.42.7.1702"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1159\/000063365"},{"key":"e_1_2_5_31_2","first-page":"48","article-title":"Clinical and bacteriological evaluation of nadifloxacin 1% cream in patients with acne vulgaris: a double blind, phase III comparison study versus erythromycin 2% cream","volume":"16","author":"Plewig G","year":"2006","journal-title":"Eur J Dermatol"}],"container-title":["International Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-4632.2010.04506.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-4632.2010.04506.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T01:25:25Z","timestamp":1697333125000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-4632.2010.04506.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,30]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["10.1111\/j.1365-4632.2010.04506.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-4632.2010.04506.x","archive":["Portico"],"relation":{},"ISSN":["0011-9059","1365-4632"],"issn-type":[{"value":"0011-9059","type":"print"},{"value":"1365-4632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,30]]},"assertion":[{"value":"2010-08-30","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}